MoneyWorks4Me

A fair growth of 6.04% in the revenue at Rs. 2768.65 millions was reported in the March 2022 quarter as compared to Rs. 2610.86 millions during year-ago period.The company almost doubled its revenue to Rs. 173.32 millions  from Rs. 8.64 millions in the quarter ended March 2022.Operating profit for the quarter ended March 2022 decreased to 215.70 millions as compared to 327.00 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 2768.65 2610.86 6.04 9429.27 11239.73 -16.11 9429.27 11239.73 -16.11
Other Income 90.78 49.06 85.04 420.68 473.71 -11.19 420.68 473.71 -11.19
PBIDT 215.70 327.00 -34.04 -14.87 1428.38 -101.04 -14.87 1428.38 -101.04
Interest 5.77 3.70 55.95 20.74 13.01 59.42 20.74 13.01 59.42
PBDT 209.93 323.30 -35.07 -35.61 1415.37 -102.52 -35.61 1415.37 -102.52
Depreciation 212.68 199.03 6.86 831.88 758.92 9.61 831.88 758.92 9.61
PBT -2.75 124.27 -102.21 -867.49 656.45 -232.15 -867.49 656.45 -232.15
TAX -176.07 115.63 -252.27 -313.18 115.63 -370.85 -313.18 115.63 -370.85
Deferred Tax -176.07 109.43 -260.90 -315.55 109.43 -388.36 -315.55 109.43 -388.36
PAT 173.32 8.64 1906.02 -554.31 540.82 -202.49 -554.31 540.82 -202.49
Equity 140.81 140.81 0.00 140.81 140.81 0.00 140.81 140.81 0.00
PBIDTM(%) 7.79 12.52 -37.80 -0.16 12.71 -101.24 -0.16 12.71 -101.24
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..